156
Participants
Start Date
August 31, 2002
Primary Completion Date
May 31, 2003
Study Completion Date
May 31, 2003
Placebo 0.01 mL
2-week placebo lead-in period (0.01 mL) followed by 4 weeks of Placebo 0.01 mL subcutaneously injected twice daily
Placebo 0.02 mL
2-week placebo lead-in period (0.01 mL) followed by 4 weeks of Placebo 0.02 mL subcutaneously injected twice daily
Placebo 0.03 mL
2-week placebo lead-in period (0.01 mL) followed by 4 weeks of Placebo 0.03 mL subcutaneously injected twice daily
Placebo 0.04 mL
2-week placebo lead-in period (0.01 mL) followed by 4 weeks of Placebo 0.04 mL subcutaneously injected twice daily
AC2993 2.5 mcg
2-week placebo lead-in period (0.01 mL) followed by 4 weeks of AC2993 2.5 mcg (0.01 mL) subcutaneously injected twice daily
AC2993 5.0 mcg
2-week placebo lead-in period (0.01 mL) followed by 4 weeks of AC2993 5.0 mcg (0.02 mL) subcutaneously injected twice daily
AC2993 7.5 mcg
2-week placebo lead-in period (0.01 mL) followed by 4 weeks of AC2993 7.5 mcg (0.03 mL) subcutaneously injected twice daily
AC2993 10.0 mcg
2-week placebo lead-in period (0.01 mL) followed by 4 weeks of AC2993 10.0 mcg (0.04 mL) subcutaneously injected twice daily
Carolina Advanced Research, Cary
Clinical Research Group of North Georgia, Blairsville
Jacksonville Center for Clinical Research, Jacksonville
Radiant Research-Gainsville, Gainsville
Diagnostic Clinic, Clearwater
Radiant Research-Pinellas Park, Pinellas Park
Innovative Clinical Trials, Birmingham
Healthsouth Clinical Research, Birmingham
Mississippi Medical Research, LLC, Gulfport
Fallen Timbers Internal Medicine, LLC, Maumee
Radiant Research-Edina, Edina
Cedar-Crosse Research Center, Chicago
The Center for Pharmaceutical Research, Kansas City
Northshore Medical Research, LLC, Covington
Medical Research Institute, Slidell
Healthsouth Clinical Research, DeSoto
Millenium Research, Benbrook
Baylor College of Medicine/Clinical Studies Unit, Houston
Diabetes Center of the Southwest, Midland
Anshutz Outpatient Pavilion, Aurora
Radiant Research-Boise, Boise
Utah Diabetes Center at the University of Utah, Salt Lake City
Innovative Health Research, Las Vegas
Pioneer Medical Group, Bellflower
International Clinical Research Network, Chula Vista
Whittier Institute for Diabetes, La Jolla
Dr. Martinez Medical Clinic, Moreno Valley
Endocrinology Clinic of O.C., Anaheim
Bautista Research and Medical Clinic, Fresno
Richard Cherlin, M.D., Los Gatos
East-West Medical Research Institute, Honolulu
Radiant Research-Honolulu, Honolulu
Melvin Kramer, MD, Concord
Lead Sponsor
AstraZeneca
INDUSTRY